Rostislav Raykov's most recent trade in Fennec Pharmaceuticals Inc was a trade of 10,000 Common shares done at an average price of $8.6 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 03 Jul 2025 | 10,000 | 60,670 (0%) | 0% | 8.6 | 86,100 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 5,208 | 70,670 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 05 Jun 2025 | 10,000 | 65,462 (0%) | 0% | 7.8 | 77,800 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2025 | 5,208 | 75,462 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 33,334 | 86,921 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.78 per share. | 16 May 2025 | 16,667 | 70,254 (0%) | 0% | 6.8 | 113,002 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 05 May 2025 | 10,000 | 53,587 (0%) | 0% | 6.3 | 63,100 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 2,431 | 63,587 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 5.25 per share. | 04 Apr 2025 | 10,000 | 61,156 (0%) | 0% | 5.3 | 52,500 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 2,431 | 71,156 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.79 per share. | 05 Mar 2025 | 10,000 | 68,725 (0%) | 0% | 6.8 | 67,900 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,431 | 78,725 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.66 per share. | 05 Feb 2025 | 10,000 | 76,294 (0%) | 0% | 6.7 | 66,600 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 2,431 | 86,294 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 06 Jan 2025 | 7,569 | 83,863 (0%) | 0% | 6.1 | 46,020 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 06 Jan 2025 | 2,431 | 91,432 (0%) | 0% | 6.1 | 14,780 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 2,431 | 93,863 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 20 Dec 2024 | 25,000 | 91,432 (0%) | 0% | 2.7 | 67,250 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 25,000 | 1,675,000 | - | - | Stock Options | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.04 per share. | 05 Dec 2024 | 796 | 66,432 (0%) | 0% | 6.0 | 4,808 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2024 | 2,431 | 68,863 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 01 Dec 2024 | 1,635 | 67,228 (0%) | 0% | 6.1 | 10,023 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 4.31 per share. | 31 Oct 2024 | 2,431 | 66,432 (0%) | 0% | 4.3 | 10,478 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 2,431 | 68,863 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 4.94 per share. | 30 Sep 2024 | 2,431 | 66,432 (0%) | 0% | 4.9 | 12,009 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 2,431 | 68,863 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Sale of securities on an exchange or to another person at price $ 5.52 per share. | 31 Aug 2024 | 2,431 | 66,432 (0%) | 0% | 5.5 | 13,419 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 2,431 | 68,863 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 50,000 | 137,471 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 50,000 | 137,471 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 28,372 | 92,433 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 28,372 | 92,433 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 26,001 | 66,432 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 16,666 | 120,805 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Aug 2024 | 16,666 | 120,805 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 2,431 | 189,902 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 31 Jul 2024 | 2,431 | 187,471 (0%) | 0% | 6.3 | 15,206 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 01 Jul 2024 | 2,431 | 187,471 (0%) | 0% | 6.1 | 14,902 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 2,431 | 189,902 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 2,431 | 189,902 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 03 Jun 2024 | 2,431 | 187,471 (0%) | 0% | 6.8 | 16,434 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 200,000 | 1,755,902 | - | - | Stock Option | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 100,000 | 1,855,902 | - | - | Restricted Share Unit | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.11 per share. | 30 Apr 2024 | 2,431 | 187,471 (0%) | 0% | 9.1 | 22,152 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 2,431 | 189,902 (0%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 04 Apr 2024 | 44,300 | 187,471 (0%) | 0% | 10.8 | 476,269 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.89 per share. | 04 Apr 2024 | 29,700 | 231,771 (1%) | 0% | 10.9 | 323,528 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.89 per share. | 04 Apr 2024 | 14,583 | 261,471 (1%) | 0% | 10.9 | 158,872 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 03 Apr 2024 | 26,000 | 276,054 (1%) | 0% | 10.8 | 280,262 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 03 Apr 2024 | 14,584 | 302,054 (1%) | 0% | 10.8 | 157,189 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Apr 2024 | 29,167 | 316,638 (1%) | 0% | 0 | Common shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 8,540 | 271,784 | - | - | Commons Shares | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.59 per share. | 28 Dec 2023 | 8,540 | 291,127 (1%) | 0% | 1.6 | 13,579 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.55 per share. | 28 Dec 2023 | 3,656 | 287,471 (1%) | 0% | 11.6 | 42,227 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 7.69 per share. | 08 Nov 2023 | 17,049 | 290,582 (1%) | 0% | 7.7 | 131,107 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 08 Nov 2023 | 7,995 | 282,587 (1%) | 0% | 7.9 | 63,161 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2023 | 74,793 | 1,596,040 | - | - | Option Contract | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.59 per share. | 03 Nov 2023 | 74,793 | 307,631 (1%) | 0% | 1.6 | 118,921 | Common shares |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 175,000 | 1,583,333 | - | - | Stock Option | |
| Fennec Pharmaceuticals Inc | Rostislav Raykov | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 87,500 | 1,670,833 | - | - | Restricted Share Unit |